Commonwealth Bank of Australia (AU:CBA) has released an update.
The Commonwealth Bank of Australia (CBA) has announced its new status as a substantial holder in Australian Clinical Labs Ltd, with a total voting power of 5.06%. This significant investment is the result of CBA and its related bodies corporate acquiring over 10 million fully paid ordinary shares. The bank’s relevant interests are tied to its control over voting and disposal rights in affiliated investment entities.
For further insights into AU:CBA stock, check out TipRanks’ Stock Analysis page.
